Science
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) Has Recovered -24.67% To Date, But An Additional -93.17% Is Possible.
In last trading session, Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) saw 1.55 million shares changing hands with its beta currently measuring 0.35. Company’s recent per share price
